William Blair initiates coverage of Vor Biopharma with outperform rating
VOR•William Blair initiated coverage of Vor Biopharma with an outperform rating.
Related News
US chip-related stocks advance on upbeat AI demand outlook
SMH•
NCR Voyix sets third-quarter earnings release
VYX•
XPEL to host third-quarter 2026 results conference call
XPEL•
Mobiquity Technologies seeks to expand commercial relationships to grow GrowthOS revenue
MOBQ•
PTC launches PTC Jetstream to connect enterprise collaboration with product development
PTC•